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Abstract
Background: Pyrethroid insecticide-treated mosquito nets are massively being scaled-up for
malaria prevention particularly in children under five years of age and pregnant mothers in sub-
Saharan Africa. However, there is serious concern of the likely evolution of widespread pyrethroid
resistance in the malaria vector Anopheles gambiae s.l. due to the extensive use of pyrethroid
insecticide-treated mosquito nets. The purpose of this study was to ascertain the status of
pyrethroid resistance in An. gambiae s.l. in western Uganda.
Methods: Wild mosquitoes (1–2 days old) were exposed in 10 replicates to new nets impregnated
with K-othrine (Deltamethrin 25 mg/m2), Solfac EW50 (Cyfluthrin 50 mg/m2) and Fendona 6SC
(Cypermethrin 50 mg/m2) and observed under normal room temperature and humidity
(Temperature 24.8°C–27.4°C, Humidity 65.9–45.7). A similar set of mosquitoes collected from the
control area 80 km away were exposed to a deltamethrin 25 mg/m2 impregnated net at the same
time and under the same conditions. The 10-year mean KDT50 and mortality rates for each of the
three pyrethroid insecticides were compared using the Student t-test.
Results: A significant increase in the mean knockdown time (KDT50) and mean mortality rate were
observed in almost all cases an indication of reduced susceptibility. The overall results showed a
four-fold increase in the mean knockdown time (KDT50) and 1.5-fold decrease in mortality rate
across the three pyrethroid insecticides. There was a significant difference in the 10-year mean
KDT50 between deltamethrin and cyfluthrin; deltamethrin and cypermethrin, but no significant
difference between cyfluthrin and cypermethrin. The 10-year mean difference in KDT50 for
mosquitoes exposed to deltamethrin from the control site was significantly different from that of
mosquitoes from the intervention site (p<0.05, t=3.979, 9df). The 10-year mean difference in
mortality rate between deltamethrin (84.64%); cyfluthrin (74.18%); cypermethrin (72.19%) and the
control (90.45%) showed a significant decline in mortality across all the three insecticides.
Conclusion: Generally the results showed a trend of increase in mosquito resistance status with
cross-resistance against all the three pyrethroid insecticides. This study reveals for the first time
the development of pyrethroid resistance in An. gambiae s.l. in Western Uganda. It is therefore
strongly recommended that the impact of this development on malaria control efforts be closely
monitored and alternative fabric treatments be considered before this problem curtails community
wide implementation of this malaria control strategy in Uganda.
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In Africa, malaria is still the leading cause of childhood
and maternal ill health and death [1]. In Uganda the bur-
den of malaria is unacceptably very high being accounta-
ble for 20–40% of out-patient attendance at health
facilities, 14% of in-patient deaths and 20–23% of child-
hood mortality[2]. The Ministry of Health in Uganda esti-
mates 70,000–110,000 malaria-specific deaths every year
and US$24.7 annual per capita expenditure on malaria
treatment [2]. The problem has been compounded by the
evolution of both drug and insecticide resistance to the
commonly used antimalarials and insecticides respec-
tively [3][4][5][6][7]. A number of novel technologies
have been developed to combat malaria including insecti-
cide treated nets (ITNs) and malaria vaccines but the vac-
cines have shown limited efficacy and need further
development [3]. Pyrethroid insecticides being cost-effec-
tive, highly insecticidal at low dosage and highly biode-
gradable with low mammalian toxicity were
recommended by WHO Pesticides Evaluation Scheme
(WHO-PES) for large-scale use on mosquito bed nets for
malaria prevention [4]. Trials of pyrethroid-impregnated
mosquito bed nets demonstrated protective efficacy in the
range of 20–70% with potential to alleviate the burden of
malaria in sub-Saharan Africa [5-7]. Pyrethroid-impreg-
nated nets are therefore being massively scaled-up in
Africa, but there is serious concern about the likely evolu-
tion of widespread pyrethroid resistance. In Kenya, as
early as 1991, there was a reduction in permethrin suscep-
tibility in Anopheles gambiae one year after introduction of
small-scale pyrethroid treated nets, but not from villages
without the nets [8]. Pyrethroid resistance in An. gambiae
s.s. has also been widely reported in West and Central
Africa [9-13]. This resistance is mainly associated with tar-
get site insensitivity arising from a single point mutation
in the sodium channel gene, often referred to as knock-
down resistance (kdr) characterized by a leucine-phenyla-
lanine mutation in West Africa [14] and leucine-serine
mutation in East Africa [15]. Both West and East African
kdr mutations have recently been reported in a population
of An. gambiae s.s. from Central Africa [11,12]. In view of
the above reports and the fact that no such a study had
ever been conducted in Uganda, a cross-sectional survey
was conducted in Kamwenge District of western Uganda,
where donor-funded integrated malaria control pro-
grammes involving distribution of free pyrethroid -treated
nets have been going on since 1998. The purpose of this
study was to determine the prevalence of pyrethoid insec-
ticide resistance in malaria vectors in this region.
Materials and methods
Kamwenge District in western Uganda was purposefully
selected because previous malariometric surveys showed
that the district is holoendemic for malaria and as such it
had benefited from the German Technical Coopera-
tion(GTZ) funded Basic health malaria control pro-
grammes and many other malaria programmes under
various NGOs funded by the Global Funds for HIV/AIDS,
Malaria and TB. The design of the study was a multi-stage
cross sectional survey with time taken for the median
mosquito to be knocked down by each of the three pyre-
throid insecticides and the 24 hrs post-exposure mortality
rate being the units of observation once every year. Mos-
quito pupae were collected from roadside water pools
from five parishes, namely Butemba, Kiziba, Rukooko,
Masaka and Nkongoro, and raised to adults in the labora-
tory. All the mosquitoes collected were identified using
morphological keys [16] and they all belonged to An.
gambiae complex. One to two days old adult mosquitoes
were exposed to new nets impregnated with K-othrine
(Deltamethrin 25 mg/m2), Solfac EW50 (Cyfluthrin 50
mg/m2)and Fendona 6SC (Cypermethrin 50 mg/m2) and
observed under normal room temperature and humidity
(temperature 24.8°C–27.4°C, humidity 65.9–45.7) for
the time taken for the median mosquito (50%) to be
knocked down and for the 24 hrs post-exposure mortality
rate. Each year, new nets were bought and cut into pieces
and wrapped on locally made mosquito cages and there-
after a batch of eleven mosquitoes introduced into the
cages in 10 test replicates for each of the three insecticides.
A similar set of mosquitoes collected from the control area
80 km away were exposed to a deltamethrin 25mg/m2
impregnated net at the same time and under the same
conditions. The control area was purposively selected,
with hypo-endemic malaria, relatively cool and had no
mosquito control bed net project because of low malaria
prevalence. The bed net usage in the control area was esti-
mated at < 5% while in the intervention area at 80% as
malaria prevalence was very high (70–80% of OPD
attendance). All knocked down mosquitoes were
removed from the cages by use of a mouth aspirator, put
in recovery cups provided with glucose soaked in cotton
wool and mean mortality rate after 24 hrs recorded. The
mean values for the KDT50 and mortality rates for the
three pyrethroid insecticides were compared using the
Student t-test. It was assumed that if 10 measurements
with a sample of 110 mosquitoes per year are made for
each insecticide with an alpha error of 0.05 and standard
deviation of 8.0 (from previous studies), a comparison of
the mean knockdown times for the three insecticides
would give a power to detect a 8% increase in knockdown
time per year of 80.43%. Therefore, a sample of 110 mos-
quitoes per insecticide per year was considered sufficient
to detect the desired effect i.e. a significant decline in pyre-
throid effect over time.
Results
The susceptibility of adult mosquitoes (reared from larval
collection) to deltamethrin, cyfluthrin and cypermethrin
from 1998–2007 is presented in Table 1.Page 2 of 5
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increase in the mean knockdown time(KDT50) and
decrease in the mean mortality rates. The overall results
showed a four-fold increase in the mean knockdown time
(KDT50) and 1.5-fold decrease in mortality rate across the
three cyano-pyrethroids from 1998–2007. The 10-year
mean KDT50 for mosquitoes exposed to deltamethrin
from the intervention site was 43.83(95%CI =30.37-
57.28) which showed a significant increase over the 10-
year period (p<0.05, t=7.4, 9df) while  that of cyfluthrin
was 52.57(95%CI=35.5-69.6) and cypermethrin was
54.1(95%CI=36.2-71.9) both of which showed a signifi-
cant increase over the 10 year period (p<0.05, t=6.9, 9df).
The 10-year mean KDT50 for mosquitoes exposed to del-
tamethrin from the control site was 22.08(95%CI=20.75-
23.41) which was significantly different from that of mos-
quitoes from the intervention site (p<0.05, t=3.979, 9df).
The 10-year mean difference in mortality rate for mosqui-
toes in the intervention site exposed to deltamethrin
84.64% (95%CI = 75.25–94.03); cyfluthrin 74.18%
(95%CI = 65.76–82.60); cypermethrin 72.19(95%CI =
65.08–79.30) and mosquitoes from the control site
exposed to deltamethrin 90.45 (95% CI = 84.06–96.84)
was significant (p < 0.05) and showed a significant
decline in mortality across all the three pyrethroid insecti-
cides.
Discussion
Pyrethroid insecticides are neurotoxins and share many
characteristics with DDT including a negative temperature
coefficient, a rapid knockdown effect followed by a lethal
effect [17]. Neurophysiological studies show that the
knockdown effect is caused by poisoning of the peripheral
nerves [18,19] and the lethal effect is due to an irreversible
damage to both the peripheral and central neurons which
occurs when poisoning takes long [20]. At the molecular
level, this poisoning tend to interfere with the sodium
channels, GABA (gamma-aminobutyric acid) activated
chloride channels and membrane bound ATPase causing
permanent depolarization of the peripheral and central
neurons[18,19]. Preferential heavy use of pyrethroids has
as earlier predicted resulted in extensive selection for
resistance in many agricultural pests and various disease
vectors [21,22]. Insecticide target site alteration conferred
by the kdr gene and metabolic resistance due to amplifica-
tion of oxidative detoxifying enzymes (acetylcholineste-
rases or glutathione-s-transferases) and co-factors, e.g.
cytochrome P450 [17,23,24], have been widely reported
in An. gambiae s.l. due to selection pressure as a result of
extensive use of pyrethroid insecticides for malaria control
and pest control in Agriculture [9-13,23]. However, most
studies have shown that reduced susceptibility to pye-
throid insecticides by An. gambiae s.l. is mainly due to
increased target site insensitivity caused by the kdr allele
[9,14,24,25]. Increase in the knockdown time as well as
reduction in mortality rate have been accepted as an indi-
cator of decline in the pyrethroid effect in An. gambiae s.l.
[8,9,13,25]. A comparative analysis of the mean knock-
down time (KDT50) and the mean post-exposure 24 hrs
mortality rate for the three pyrethroid insecticides showed
a significant increase in the mean KDT50 and a significant
reduction in the mean mortality rate over the 10 year-
period, an indication of the existence of knockdown
resistance conferred by kdr alleles and/or metabolic resist-
ance in An. gambiae s.l. in western Uganda. Although the
24 h post-exposure mortality rate using deltamethrin
showed a slight decrease compared to cyfluthrin and
cypermetrin, the overall reduction in the mean mortality
rate across all the three cyano-pyrethroids over the 10 year
period suggests cross-resistance to all pyrethroids. The
slight decline in mortality rate and increase in KDT50
observed in the control mosquitoes could be explained by
Table 1: Mean mortality rate and mean knockdown time (min) for the median (50%) in a batch of 11Anopheles mosquitoes in 10 
replicates exposed to K-othrine (Deltamethrin 25 mg/m2), Solfac EW50 (Cyfluthrin 50 mg/m2)and Fendona 6SC (Cypermethrin 50 
mg/m2) impregnated mosquito nets.
Year Deltamethrin Cyfluthrin Cypermethrin Control*
KDT50 mortality % KDT50 mortality % KDT50 mortality % KDT50 mortality %
1998 19.2 100 21.7 90.2 20.3 88.7 19 100
1999 23.9 100 22.6 89.14 24.2 86 21.2 100
2000 25.4 100 28.1 82.7 27.6 78 20 100
2001 33.6 89.1 42.3 80.7 40.8 74.5 22 100
2002 38.5 90.2 51.5 77 52.8 72.5 23.2 80
2003 46.2 82 56.7 74 61.7 67.3 22 90
2004 50.8 76.1 62.9 66 67.4 69.5 21.4 89
2005 62.1 74 72.4 64.5 74.6 66.2 22.5 85.5
2006 65.9 69.8 77.3 61 83.2 60.8 25 80
2007 72.7 65.2 90.2 56.6 88.4 58.4 24.5 80
Mean 43.83 84.64 52.57 74.18 54.10 72.19 22.08 90.45
* DeltamethrinPage 3 of 5
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of pyrethroid agro-chemicals in agriculture [21,25]. How-
ever, follow up studies need to investigate this possibility.
This means that the fight against pyrethroid resistance
needs concerted effort by all stakeholders and alternate
use of pyrethroid insecticides with other types of insecti-
cides in both public health and agricultural production is
urgently needed in order to eliminate any differential
advantage of the resistant individuals to pyrethroid insec-
ticides.
There were some limitations in this study. First, Molecular
differentiation of sibling species in Anopheles gambiae
complex was not done which means that sibling species
composition may differ between the intervention and
control study sites. 
Secondly it was not possible to use a laboratory suscepti-
ble colony for the control test because it was not available
anywhere in Uganda. This would be an ideal comparison
as it would ensure consistent 100% mortality and a con-
stant KDT50 in the control mosquito population.
Conclusion and recommendations
Generally the results showed a trend of increase in mos-
quito resistance status with cross-resistance against all the
three pyrethroid insecticides. This study reveals for the
first time the development of pyrethroid resistance in An.
gambiae s.l. in western Uganda. However, there is need for
a molecular confirmation of the existence of the kdr alleles
or to establish the type of resistance and extend the
research to others areas in Uganda. At operational level,
there is great need for continuous pyrethroid susceptibil-
ity testing in monitoring the efficacy of pyrethroid insecti-
cide treated-mosquito nets. In addition, other alternative
chemical compounds with little likelihood of cross resist-
ance need to be developed before ITNs use in Uganda is
curtailed by widespread pyrethroid insecticide resistance.
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